| 1 |
任成山，钱桂生. 慢性阻塞性肺疾病发病机制研究现状与展望[J/CD]. 中华肺部疾病杂志(电子版), 2009, 2(2): 104-115.
|
| 2 |
Han MK, Agusti A, Calverley PM, et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD[J]. Am J Respir Crit Care Med, 2010, 182(5): 598-604.
|
| 3 |
Eltboli O, Brightling CE. Eosinophils as diagnostic tools in chroniclung disease[J]. Expert Rev Respir Med, 2013, 7(1): 33-42.
|
| 4 |
Bafadhel M, Saha S, Siva R, et al. Sputum IL-5 concentration is associated with a sputum eosinophilia and attenuated by corticosteroid therapy in COPD[J]. Respiration, 2009, 78(3): 256-262.
|
| 5 |
Bafadhel M, McKenna S, Terry S, et al. Acute exacerbations of COPD：identification of biological clusters and their biomarkers[J]. Am J Respir Crit Care Med, 2011, 184(2): 662-671.
|
| 6 |
Saha S, Brightling CE. Eosinophilic airway inflammation in COPD[J]. Int J Chron Obstruct Pulmon, 2006, 1(1): 39-47.
|
| 7 |
Nair P, Ochkur SI, Protheroe C, et al. Eosinophil peroxidase in sputum represents a unique biomarker of airway eosinophilia[J]. Allergy, 2013, 68(9): 1177-1184.
|
| 8 |
Snijders D, Agostini S, Bertuola F, et al. Markers of eosinophilic and neutrophilic inflammation in bronchoalveolar lavage of asthmatic and atopic children[J]. Allergy, 2010, 65(8): 978-985.
|
| 9 |
Singh D, Kolsum U, Brightling CE, et al. Eosinophilic inflammation in COPD: prevalence and clinical characteristics[J]. Eur Respir J, 2014, 44(6): 1697-1700.
|
| 10 |
Bafadhel M, McKenna S, Terry S, et al. Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial[J]. Am J Respir Crit Care Med, 2012, 186(1): 48-55.
|
| 11 |
Eltboli O, Mistry V, Barker B, et al. Relationship between blood and bronchial submucosal eosinophilia and reticular basement membrane thickening inchronic obstructive pulmonary disease[J]. Respirology, 2015, 20(4): 667-670.
|
| 12 |
Soter S, Barta I, Antus B. Predicting sputum eosinophilia in exacerbations of COPD using exhaled nitric oxide[J]. Inflammation, 2013, 36(5): 1178-1185.
|
| 13 |
Chou KT, Su KC, Huang SF, et al. Exhaled nitric oxide predicts eosinophilic airway inflammation in COPD[J]. Lung, 2014, 192(4): 499-504.
|
| 14 |
张静，王新茂，陈亚红，等. 关于诱导痰嗜酸性粒细胞与COPD临床表型的研究[A]. 中华医学会、中华医学会呼吸病学分会．中华医学会呼吸病学年会——2013第十四次全国呼吸病学学术会议论文汇编[C]. 中华医学会、中华医学会呼吸病学分会：2013：1.
|
| 15 |
Pizzichini E, Pizzichini MM, Gibson P, et al. sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis[J]. Am J Respir Crit Care Med, 1998, 158(5 Pt 1): 1511-1517.
|
| 16 |
Brightling CE, Monteiro W, Ward R, et al. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial[J]. Lancet, 2000, 356(9240): 1480-1485.
|
| 17 |
Leigh R, Pizzichini MM, Morris MM, et al. Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment[J]. Eur Respir J, 2006, 27(5): 964-971.
|
| 18 |
Pascoe S, Locantore N, Dransfield MT, et al. Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: asecondary analysis of data from two parallel randomised controlled trials[J]. LancetRespir Med, 2015, 3(6): 435-442.
|
| 19 |
Siva R, Green RH, Brightling CE, et al. Eosinophilic airway inflammation and exacerbations of COPD: a randomized controlled trial[J]. Eur Respir J, 2007, 29(5): 906-913.
|
| 20 |
Corren J. Inhibition of interleukin-5 for the treatment of eosinophilic diseases[J]. Discov Med, 2012, 13(71): 305-312.
|
| 21 |
Asia Pacific COPD Roundtable Group.Golbal initiative for chronic obstructive lung disease.Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease：an Asia-Pacific perspective[J]. Respirology, 2005, 10(1): 9-17.
|